All Antibiotics articles
-
NewsShorter treatment regimens are safe options for preventing active tuberculosis
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully completed both regimens and suffered few adverse side effects.
-
NewsWhat drives food allergies? New study pinpoints early-life factors that raise risk - including microbiome
A new study involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food. Genetics alone cannot fully explain food allergy trends, pointing to interactions between genes, skin health, the microbiome, and environmental exposures.
-
NewsClinical data gaps keeping life-saving antibiotics from children
Antibiotics that could treat severe infections in babies and children aren’t accessible due to a lack of data around safety and dosage. Of 12 antibiotics recommended for serious bloodstream infections caused by a harmful, Gram-negative bacteria, only six were licensed in children aged under 12 and just three in babies.
-
NewsAntibiotic therapy: is shorter just as effective?
Shorter-duration antibiotic therapy shows comparable success to longer-duration treatment in children with community-acquired pneumonia. However, a general conclusion about a shortened treatment duration is not possible, Tthe authors of a new study say.
-
NewsHow a potential antibiotics ban could affect apple growers
Antibiotic resistance in human and animal health is on the forefront of public debate, but it’s a less well-known issue in plant agriculture. However, antibiotics are important tools in fruit production, and their efficacy hinges on avoiding resistance in disease-causing bacteria. Source: Tianna DuPont, WSU Extension Apple ...
-
NewsPine bark removes pharmaceutical residues from wastewater – an affordable way to keep antibiotics out of nature
Researchers have developed a pine‑bark–based water‑treatment medium that efficiently removes antibiotics as well as residues of blood‑pressure and antidepressant medicines from wastewater treatment plant effluent.
-
NewsWhy don’t antibiotic-making bacteria self-destruct?
Scientists discovered a promising new antibiotic in a soil sample. The molecule, lariocidin, is produced by the microbe Paenibacillus and shows broad activity against pathogenic bacteria. Now, the researchers report how Paenibacillus avoids harm by its own antibiotic.
-
NewsResearchers revive failing antibiotics with two-faced Janus nanoparticles
Researchers have restored the power of failing antibiotics by combining them with two-sided nanoparticles, ultra-small building blocks of materials less than 100 nanometers across. The nanoparticles showed a remarkable ability to compromise bacterial cell walls, leaving them vulnerable to attack.
-
NewsNew test shows which antibiotics actually work
Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory conditions. A critical factor is whether the active substances actually kill the pathogens in the body. Researchers have presented a new method for measuring how effectively antibiotics kill bacteria.
-
NewsAntibiotics in sediments may quietly boost greenhouse gas emissions
A study shows that pharmaceutical pollution alters nitrogen cycling and greenhouse gas emissions in coastal sediments. Even environmentally relevant antibiotic concentrations increased N₂O release, suggesting that widespread contamination may enhance estuarine climate forcing.
-
NewsResearchers use robotics to find potential new antibiotic among hundreds of metal complexes
Researchers have used a cutting-edge robotic system capable of synthesising hundreds of metal complexes to develop a possible antibiotic candidate - offering fresh hope in the global fight against drug-resistant infections.
-
NewsThe antibiotic delafloxacin emerges as a potential therapeutic alternative against Legionella
A study shows, in an experimental laboratory model, that delafloxacin inhibits the intracellular replication of Legionella more effectively than one of the current standard treatments.
-
NewsStudy reveals high stakes of early immune development—and a potential probiotic fix
Scientists find that certain gut bacteria are essential for building immune defenses during infancy, pointing to new strategies for protecting children’s health. They have identified a way to preserve healthy immune development even when infants need antibiotic treatment.
-
NewsPlant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
Plant derived phenolic acids can dramatically enhance the activity of existing antibiotics against multidrug resistant E. coli, offering a promising new tool in the global fight against antimicrobial resistance.
-
NewsAntibiotics could trigger immune response through gut microbiome metabolites
Researchers report how one of the most abundant gut bacteria responds to tetracyclines, a class of commonly prescribed antibiotics. Newly characterized signals released by the bacterium could aid the host’s immune response, inhibit pathogens and restructure the gut microbiome.
-
NewsResearchers rescue antibiotics from resistance using phototherapy
Researchers have used phototherapy to inhibit a protein in E. coli bacteria that makes them resistant to antibiotics. This new method, if proven safe and effective in living organisms, holds promise for rescuing the effectiveness of antibiotics that bacteria have become resistant to.
-
NewsNew study reveals how a common antibiotic disrupts nitrogen cycling and boosts greenhouse gas emissions in estuaries
Antibiotics may have far reaching impacts on wetland chemistry, according to a new study that identifies the bacteria responsible for breaking down the antibiotic sulfamethoxazole and links this process to increased emissions of nitrous oxide, a potent greenhouse gas.
-
NewsPhase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
-
NewsWastewater from most countries favours non-resistant bacteria
Municipal wastewater contains a large range of excreted antibiotics and has therefore long been suspected to be a spawning ground for antibiotic-resistant bacteria. By testing the potential of untreated municipal wastewater from 47 countries to select for resistant E. coli, researchers show that while some samples indeed do so, most instead suppress them.
-
NewsEmerging pollutants threaten efficiency of wastewater treatment: New review highlights urgent research needs
A new scientific review has shed light on how emerging pollutants commonly found in wastewater are disrupting biological phosphorus removal processes, posing risks to water quality and ecological health. The study examines how pharmaceuticals, microplastics, and industrial chemicals interfere with the key microorganisms responsible for phosphorus removal in wastewater treatment plants.